XENETIC BIOSCIENCES, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+18.1% +$117K
$766K
Cost of Revenue
—
Gross Profit
—
R&D↓-25.8% -$269K
$773K
D&A
—
Operating Income↓-9.1% -$45K
$-545K
EBITDA↓-9.1% -$45K
$-545K
Interest Expense
—
Interest Income
—
Other Income/Expense
—
Pretax Income
—
Tax Provision
$0
Net Income↓-16.8% -$73K
$-510K
Gross Margin
—
Operating Margin↑+28.3pts
-53.0%
Net Margin↑+21.4pts
-49.7%
Effective Tax Rate
—
Revenue YoY Variation↑+21.6pts
18.1%
Income YoY Variation↓-65.5pts
-9.1%
Revenue QoQ Variation↓-31.0pts
-25.4%
Income QoQ Variation↓-37.9pts
24.8%